Need all Congresses? Press Enter for expanded federal results.

Drug safety, medical device, and laboratory regulation

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
180
Coverage
110th-119th
Current view
114th Congress
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
180 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HR 3618
Orphan Drug Fairness Act
114th Referred to the Subcommittee on Health. October 2, 2015
HR 3539
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
114th Referred to the House Committee on Ways and Means. September 17, 2015
HR 3381
Childhood Cancer STAR Act
114th Received in the Senate. December 7, 2016
HR 3304
Foreign Manufacturers Legal Accountability Act of 2015
114th Referred to the Subcommittee on Biotechnology, Horticulture, and Research. August 25, 2015
HR 3299
Strengthening Public Health Emergency Response Act of 2016
114th Placed on the Union Calendar, Calendar No. 571. September 9, 2016
HR 3250
DXM Abuse Prevention Act of 2015
114th Placed on the Union Calendar, Calendar No. 520. July 8, 2016
HR 3163
Affordability Is Access Act
114th Referred to the Subcommittee on Health. July 24, 2015
HR 3049
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016
114th Committee on Appropriations Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Hearings held. With printed Hearing: S.Hrg. 114-633. October 21, 2015
HR 3014
Medical Controlled Substances Transportation Act of 2015
114th Ordered to be Reported by Voice Vote. November 18, 2015
HR 3012
Right to Try Act of 2015
114th Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. July 29, 2015
HR 2841
FAST Generics Act of 2015
114th Referred to the Subcommittee on Health. June 19, 2015
HR 2629
Antibiotic Development to Advance Patient Treatment Act
114th Referred to the Subcommittee on Health. June 5, 2015
HR 2623
Personal Drug Importation Fairness Act of 2015
114th Referred to the Subcommittee on Health. June 5, 2015
HR 2597
AIM Act of 2015
114th Referred to the Subcommittee on Health. June 5, 2015
HR 2549
To amend the HITECH Act with respect to accessing, sharing, and using health data for research purposes.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2547
Surrogate Endpoint Improvement and Utilization Act of 2015
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2480
CCM-CARE Act
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2479
To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to...
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2459
Delivering Antimicrobial Transparency in Animals Act of 2015
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2455
To amend the Federal Food, Drug, and Cosmetic Act with respect to precision medicine.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2452
To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2445
To express the sense of Congress with respect to enabling Food and Drug Administration scientific engagement.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2444
To authorize the Commissioner of Food and Drugs to award grants for studying the process of continuous drug manufacturing.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2443
To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2438
To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial d...
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2433
To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2428
To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2427
To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2426
To amend the Federal Food, Drug, and Cosmetic Act with respect to easing regulatory burden with respect to certain class I and cl...
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2425
To amend the Federal Food, Drug, and Cosmetic Act with respect to the recognition of standards.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2424
To amend the Federal Food, Drug, and Cosmetic Act with respect to training and oversight in least burdensome appropriate means co...
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2423
To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2422
To amend the Federal Food, Drug, and Cosmetic Act with respect to third-party quality system assessment.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2416
To amend the Federal Food, Drug, and Cosmetic Act to evaluate the potential use of evidence from clinical experience to help supp...
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2415
To amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of a streamlined data review program.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2414
To facilitate the responsible communication of scientific and medical developments.
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2396
SOFTWARE Act
114th Referred to the Subcommittee on Health. May 22, 2015
HR 2338
To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance th...
114th Referred to the Subcommittee on Health. May 15, 2015
HR 2337
To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices.
114th Referred to the Subcommittee on Health. May 15, 2015
HR 2335
Stop Tampering of Prescription Pills Act of 2015
114th Referred to the Subcommittee on Health. May 15, 2015